Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4753971
Max Phase: Preclinical
Molecular Formula: C17H15BrFN3O2S
Molecular Weight: 343.38
Molecule Type: Unknown
Associated Items:
ID: ALA4753971
Max Phase: Preclinical
Molecular Formula: C17H15BrFN3O2S
Molecular Weight: 343.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Br.N=C(N)SCc1ccc(CN2C(=O)C(=O)c3cccc(F)c32)cc1
Standard InChI: InChI=1S/C17H14FN3O2S.BrH/c18-13-3-1-2-12-14(13)21(16(23)15(12)22)8-10-4-6-11(7-5-10)9-24-17(19)20;/h1-7H,8-9H2,(H3,19,20);1H
Standard InChI Key: YVFMEVAVUHOGRO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 343.38 | Molecular Weight (Monoisotopic): 343.0791 | AlogP: 2.68 | #Rotatable Bonds: 4 |
Polar Surface Area: 87.25 | Molecular Species: BASE | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.54 | CX LogP: 2.74 | CX LogD: 0.40 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.51 | Np Likeness Score: -1.08 |
1. Dinavahi,SS.; Gowda,R.; Bazewicz,CG.; Battu,MB.; Lin,JM.; Chitren,RJ.; Pandey,MK.; Amin,S.; Robertson,GP.; Gowda,K.. (2020) Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents., 187 [PMID:31887569] [10.1016/j.ejmech.2019.111962] |
Source(1):